文献速递肝病

肝纤维化过程中的细胞器应激与细胞器间交互改变

Organelle stress and alterations in interorganelle crosstalk during liver fibrosis.
PubMed 文献 · Hepatology · 2023-01-03

综述总结肝纤维化中细胞器特异性功能障碍及细胞器间交互改变的最新发现与机制,指出纠正细胞器功能可开辟新的治疗途径,并讨论临床转化面临的潜在挑战。

要点

  • 病毒、细菌、寄生虫感染、酒精、药物或基因突变长期作用可破坏细胞器功能完整性,参与慢性肝病及肝纤维化发生发展。
  • 肝纤维化以细胞外基质进行性积聚导致组织瘢痕形成为特征,未治疗可进展至肝硬化、肝功能失代偿和肝细胞癌。
  • 针对减少细胞器应激、改善细胞器间交互并恢复细胞器稳态的策略,可能成为避免肝移植的潜在临床选择。

核心结论

  • 深入理解纤维化的细胞器层面调控有助于设计有效的抗纤维化治疗,聚焦于减少细胞器应激、限制细胞器损伤、改善细胞器间交互及恢复细胞器稳态,并可能成为避免肝移植的潜在临床选择。

研究设计与样本

  • 综述,汇总近期关于肝纤维化中细胞器特异性功能障碍及细胞器间交互改变的发现与机制。

主要发现

  • 长期暴露于病毒、细菌、寄生虫感染、酒精、药物等应激原或基因突变常破坏细胞器功能完整性,在包括慢性肝病在内的多种疾病启动和进展中起关键作用。
  • 由于缺乏可使肝硬化消退或逆转的治疗选择,肝移植是目前终末期肝病唯一可用的治疗,但可用供体器官供应有限、终身免疫抑制方案的不良反应及经济因素构成主要挑战并限制其应用。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The synchronous functioning and quality control of organelles ensure cell survival and function and are essential for maintaining homeostasis. Prolonged exposure to stressors (viruses, bacteria, parasitic infections, alcohol, drugs) or genetic mutations often disrupt the functional integrity of organelles which plays a critical role in the initiation and progression of several diseases including chronic liver diseases. One of the most important pathologic consequences of chronic liver diseases is liver fibrosis, characterized by tissue scarring due to the progressive accumulation of extracellular matrix components. Left untreated, fibrosis may advance to life-threatening complications such as cirrhosis, hepatic decompensation, and HCC, which collectively accounts for ∼1 million deaths per year worldwide. Owing to the lack of treatment options that can regress or reverse cirrhosis, liver transplantation is currently the only available treatment for end-stage liver disease. However, the limited supply of usable donor organs, adverse effects of lifelong immunosuppressive regimes, and financial considerations pose major challenges and limit its application. Hence, effective therapeutic strategies are urgently needed. An improved understanding of the organelle-level regulation of fibrosis can help devise effective antifibrotic therapies focused on reducing organelle stress, limiting organelle damage, improving interorganelle crosstalk, and restoring organelle homeostasis; and could be a potential clinical option to avoid transplantation. This review provides a timely update on the recent findings and mechanisms covering organelle-specific dysfunctions in liver fibrosis, highlights how correction of organelle functions opens new treatment avenues and discusses the potential challenges to clinical application.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Sinha S, Hassan N, Schwartz RE, et al. Organelle stress and alterations in interorganelle crosstalk during liver fibrosis. Hepatology. 2023. PMID: 36626634. doi:10.1097/HEP.0000000000000012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。